Imfinzi

Imfinzi Indications/Uses

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
Non-Small Cell Lung Cancer (NSCLC): IMFINZI is indicated for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
Small Cell Lung Cancer (SCLC): IMFINZI in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in